Evidence map›Paper›PMID 18528404›Full record

ArticleGenes and immunity2008

Variation in the ICAM1 gene is not associated with severe malaria phenotypes.

A E Fry, S Auburn, M Diakite, A Green, A Richardson, J Wilson, M Jallow, F Sisay-Joof, M Pinder, M J Griffiths and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Genes and immunity, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. ICAM-1Malaria journal · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Molecular basis of human cerebral malaria development.Tropical medicine and health · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A subset of group A-like var genes encodes the malaria parasite ligands for binding to human brain endothelial cells.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  18. The host genetic diversity in malaria infection.Journal of tropical medicine · 2012
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 5 countries.

A E FryThe Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK. afry@well.ox.ac.uk
S Auburn
M Diakite
A Green
A Richardson
J Wilson
M Jallow
F Sisay-Joof
M Pinder
M J Griffiths
N Peshu
T N Williams
K Marsh
M E Molyneux
T E Taylor
K A Rockett
D P Kwiatkowski
Centre for Human Genetics · GBMRC Unit the Gambia · GMJohn Radcliffe Hospital · GBKenya Medical Research Institute · KEBlantyre Institute for Community Ophthalmology · MWLiverpool School of Tropical Medicine · GB

Funding

Medical Research Council G0600230Medical Research Council G0600230(77610)Wellcome Trust 074586Wellcome Trust 076934
6 · The paper itself

Abstract

Evidence from autopsy and in vitro binding studies suggests that adhesion of erythrocytes infected with Plasmodium falciparum to the human host intercellular adhesion molecule (ICAM)-1 receptor is important in the pathogenesis of severe malaria. Previous association studies between polymorphisms in the ICAM1 gene and susceptibility to severe malarial phenotypes have been inconclusive and often contradictory. We performed genetic association studies with 15 single nucleotide polymorphisms (SNPs) around the ICAM1 locus. All SNPs were screened in a family study of 1071 trios from The Gambia, Malawi and Kenya. Two key non-synonymous SNPs with previously reported associations, rs5491 (K56M or 'ICAM-1(Kilifi)') and rs5498 (K469E), were tested in an additional 708 Gambian trios and a case-control study of 4058 individuals. None of the polymorphisms were associated with severe malaria phenotypes. Pooled results across our studies for ICAM-1(Kilifi) were, in severe malaria, odds ratio (OR) 1.02, 95% confidence interval (CI) 0.96-1.09, P=0.54, and cerebral malaria OR 1.07, CI 0.97-1.17, P=0.17. We assess the available epidemiological, population genetic and functional evidence that links ICAM-1(Kilifi) to severe malaria susceptibility.

Indexed as

Genetic VariationPolymorphism, Single NucleotideGambiaHumansIntercellular Adhesion Molecule-1KenyaMalariaMalawiPhenotypeIntercellular Adhesion Molecule-1

Identifiers

PMID18528404
PMCPMC2657869
OpenAlexW2117131435

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.